Viromed Medical AG Long-term Investment Intensity
Viromed Medical AG long-term investment intensity. Viromed Medical AG (Q11) has a Long-term Investment Intensity of 3.9% as of September 2025. Long-term investments of €13.15 Million represent 3.9% of total assets of €339.03 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Read Q11 liabilities breakdown for a breakdown of total debt and financial obligations.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Long-term Investment Intensity of Viromed Medical AG (2023–2024)
Long-term investment intensity of Viromed Medical AG from 2023 to 2024. This chart shows how Viromed Medical AG's Long-term Investment Intensity has evolved across 2 annual periods from 2023 to 2024. As of September 2025, the intensity stands at 3.9%, reflecting long-term investments of €13.15 Million against total assets of €339.03 Million EUR.
Viromed Medical AG Long-term Investment Intensity by Year (2023–2024)
Viromed Medical AG long-term investment intensity by year from 2023 to 2024. The table below presents the year-by-year Long-term Investment Intensity for Viromed Medical AG from 2023 to 2024, covering 2 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Viromed Medical AG total assets.
| Year | LT Investment Intensity | LT Investments (EUR) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2024 | 8.4% | €21.60 Million | €255.98 Million | ▼ -16.8 pp |
| 2023 | 25.2% | €27.01 Million | €107.24 Million | — |